東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cancer- Immunological aspects." ]

切換: 標籤 | MARC模式 | ISBD

Inflammation and immunity in cancer

Seya, Tsukasa.

FindBook

Google Book

Amazon

博客來

Inflammation and immunity in cancer

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Inflammation and immunity in cancer/ edited by Tsukasa Seya ... [et al.].
其他作者:	Seya, Tsukasa.
出版者:	Tokyo :Springer Japan : : 2015.,
面頁冊數:	xi, 268 p. :ill., digital ;24 cm.
內容註:	Preface -- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis -- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis -- 3 Regulation of tumor-associated myeloid cells by innate immune signaling -- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses -- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways -- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells -- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation -- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus -- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells -- 10 Development of immunotherapy for hepatocellular carcinoma -- 11 Development of glypican-3-targeted cancer immunotherapy -- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation -- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy -- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models -- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy -- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects -- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression -- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench -- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC) -- 20 Overview on tumor immunology -- BM Epilogue.
Contained By:	Springer eBooks
標題:	Cancer - Immunological aspects. -
電子資源:	http://dx.doi.org/10.1007/978-4-431-55327-4
ISBN:	978443155327-4 (electronic bk.)

Inflammation and immunity in cancer
Inflammation and immunity in cancer[electronic resource] /edited by Tsukasa Seya ... [et al.]. - Tokyo :Springer Japan :2015. - xi, 268 p. :ill., digital ;24 cm.

Preface -- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis -- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis -- 3 Regulation of tumor-associated myeloid cells by innate immune signaling -- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses -- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways -- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells -- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation -- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus -- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells -- 10 Development of immunotherapy for hepatocellular carcinoma -- 11 Development of glypican-3-targeted cancer immunotherapy -- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation -- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy -- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models -- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy -- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects -- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression -- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench -- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC) -- 20 Overview on tumor immunology -- BM Epilogue.

This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response. The innate and acquired arms of the immune system mainly participate in tumor immune surveillance, and their activation is critically modulated by the situation of the tumor microenvironment. Many types of immune cells join the formation of the microenvironment. In particular, macrophages and dendritic cells enter the tumor mass to be main players in the inflammatory milieu of tumors. After introducing these topics, the book discusses immunotherapy for cancer patients as an outgrowth of this concept of infection and inflammation. With the contributions of leading scientists actively involved in the field of antitumor immunity study, this book encourages readers to understand the mechanism of general cancers based on inflammation and will facilitate prevention and the development of therapeutics for cancer.

ISBN: 978443155327-4 (electronic bk.)

Standard No.: 10.1007/978-4-431-55327-4doiSubjects--Topical Terms:

658008
Cancer
--Immunological aspects.

LC Class. No.: RC268.3

Dewey Class. No.: 616.994

Inflammation and immunity in cancer
LDR:03794nmm a2200313 a 4500 001 1997717
003 DE-He213
005 20151008132620.0
006 m d
007 cr nn 008maaau
008 151112s2015 ja s 0 eng d
020 $a 978443155327-4 (electronic bk.)
020 $a 9784431553267 (paper)
024 7 $a 10.1007/978-4-431-55327-4 $2 doi
035 $a 978-4-431-55327-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC268.3
072 7 $a MJCM $2 bicssc
072 7 $a MED044000 $2 bisacsh
082 0 4 $a 616.994 $2 23
090 $a RC268.3 $b .I43 2015
245 0 0 $a Inflammation and immunity in cancer $h [electronic resource] / $c edited by Tsukasa Seya ... [et al.].
260 $a Tokyo : $b Springer Japan : $b Imprint: Springer, $c 2015.
300 $a xi, 268 p. : $b ill., digital ; $c 24 cm.
505 0 $a Preface -- 1 Role of bone marrow-derived CCR1+ cells in colon cancer invasion and metastasis -- 2 PGE2-associated inflammation and gastrointestinal tumorigenesis -- 3 Regulation of tumor-associated myeloid cells by innate immune signaling -- 4 The role of PIKfyve in TLR-mediated inflammation and immune responses -- 5 Emerging roles of an innate immune regulator TAPE in the Toll-like receptor and RIG-I-like receptor pathways -- 6 Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T-cell leukemia/lymphoma cells -- 7 Tumor-associated molecular patterns: its implication in tumoricidal inflammation -- 8 Host factors involved in the propagation and pathogenesis of hepatitis C virus -- 9 HCV-induced inflammation: The role of cross-talk between HCV-infected hepatocytes and stellate cells -- 10 Development of immunotherapy for hepatocellular carcinoma -- 11 Development of glypican-3-targeted cancer immunotherapy -- 12 The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation -- 13 In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy -- 14 Enhancement of efficacy of WT1 peptide cancer vaccine by co-administration with immunopotentiating agents: Lessons from mouse models -- 15 Regulation of antigen-presentation by dendritic cells and its application to cancer immunotherapy -- 16 A new mode of CTL induction secondary to alteration of pMHCI repertoire by antigen processing defects -- 17 Progress in clinical use of CCR4 antibody for regulatory T cell suppression -- 18 Adjuvant Immunotherapy for cancer: Basic research to clinical bench -- 19 Immunological regulation of human cancer stem cell/cancer-initiating cells (CSC/CIC) -- 20 Overview on tumor immunology -- BM Epilogue.
520 $a This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response. The innate and acquired arms of the immune system mainly participate in tumor immune surveillance, and their activation is critically modulated by the situation of the tumor microenvironment. Many types of immune cells join the formation of the microenvironment. In particular, macrophages and dendritic cells enter the tumor mass to be main players in the inflammatory milieu of tumors. After introducing these topics, the book discusses immunotherapy for cancer patients as an outgrowth of this concept of infection and inflammation. With the contributions of leading scientists actively involved in the field of antitumor immunity study, this book encourages readers to understand the mechanism of general cancers based on inflammation and will facilitate prevention and the development of therapeutics for cancer.
650 0 $a Cancer $x Immunological aspects. $3 658008
650 0 $a Cancer $x Molecular aspects. $3 661419
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Immunology. $3 611031
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Oncology. $3 751006
700 1 $a Seya, Tsukasa. $3 2139033
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-4-431-55327-4
950 $a Biomedical and Life Sciences (Springer-11642)